BrahmHillelSegalMD
Infectious Disease • Tampa, FLHealthcare Associated Infections, Transplant/Immunocompromised States
Chair, Dept. of Internal Medicine, Moffitt Cancer Center
Dr. Segal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-745-7365Fax+1 813-449-8618
Summary
- Dr. Brahm Segal is an Infectious Disease specialist based in Tampa, Florida.He completed his residency in Internal Medicine at Tufts Medical Center and a fellowship in Infectious Disease at the National Institutes of Health Clinical Center. Dr. Segal has contributed to several clinical publications and participated in national guidelines related to infections in immunocompromised patients. His lab research is on innate immune responses in the tumor microenvironment. Dr. Segal has been recognized by Castle Connolly as one of America's Top Doctors and Top Doctors for Cancer.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1995 - 1997
Tufts Medical CenterResidency, Internal Medicine, 1992 - 1995
Albert Einstein College of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 2024 - 2027
NY State Medical License 1999 - 2026
MD State Medical License 1996 - 1999
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Buffalo Spree Magazine Castle Connolly, 2008, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients Start of enrollment: 2020 Nov 17
Publications & Presentations
PubMed
- Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient du...Ryutaro Kajihara, Mark D Long, Toshifumi Hoki, Hongbin Chen, Takayoshi Yamauchi
Journal for Immunotherapy of Cancer. 2025-01-25 - Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer.Jason Ricciuti, Qian Liu, A N M Nazmul H Khan, Janine M Joseph, Bert Veuskens
Gynecologic Oncology. 2025-01-06 - Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer.Spencer R Rosario, Mark D Long, Shanmuga Chilakapati, Eduardo Cortes Gomez, Sebastiano Battaglia
Nature Communications. 2024-12-05
Press Mentions
Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023- NextCure Provides Business Update and Reports Second Quarter 2022 Financial ResultsAugust 4th, 2022
- Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022
- Join now to see all
Grant Support
- Role Of Nadph Oxidase In Regulating InflammationNational Institute Of Allergy And Infectious Diseases2009–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
